{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:25Z","timestamp":1780617625337,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015777","name":"South African Medical Research Council Division of Research Capacity Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015777","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.vaccine.2026.128580","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T07:40:17Z","timestamp":1775893217000},"page":"128580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Waning of measles immunity by 5\u00a0years of age following an accelerated two-dose measles vaccine schedule at 6 and 12\u00a0months in South African children: an observational cohort study"],"prefix":"10.1016","volume":"81","author":[{"given":"Daniel J.","family":"Kapelus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heena","family":"Ranchod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney P.","family":"Olwagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthonet","family":"Koen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora A.M.L.","family":"Mutsaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabir A.","family":"Madhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"100","key":"10.1016\/j.vaccine.2026.128580_bb0005","first-page":"591","article-title":"Progress towards measles elimination \u2013 worldwide","volume":"48","author":"Antoni","year":"2025","journal-title":"Wkly Epidemiol Rec"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128580_bb0010","first-page":"519","article-title":"Lessons from the 2009 measles epidemic in South Africa. SAMJ","volume":"101","author":"Schoub","year":"2011","journal-title":"S Afr Med J"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128580_bb0015","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1186\/s12889-022-14069-w","article-title":"Measles incidence in South Africa: a six-year review, 2015\u20142020","volume":"22","author":"Yousif","year":"2022","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128580_bb0020","doi-asserted-by":"crossref","first-page":"515.e1","DOI":"10.1016\/j.cmi.2019.11.006","article-title":"Measles seroprevalence in pregnant women in soweto, South Africa: a nested cohort study","volume":"26","author":"Gieles","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128580_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055682","article-title":"Measles outbreak in South Africa: epidemiology of laboratory-confirmed measles cases and assessment of intervention, 2009\u20132011","volume":"8","author":"Ntshoe","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128580_bb0030","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz348","article-title":"Immunogenicity and safety of an early measles vaccination schedule at 6 and 12 months of age in human immunodeficiency virus (HIV)-unexposed and HIV-exposed, uninfected south african children","volume":"220","author":"Mutsaerts","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128580_bb0035","series-title":"The 2022 antenatal HIV sentinel survey [internet]","author":"Tendesayi Kufa-Chakezha","year":"2023"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128580_bb0040","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1080\/21645515.2020.1871296","article-title":"Long-term immunogenicity after measles vaccine vs. wild infection: an italian retrospective cohort study","volume":"17","author":"Bianchi","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128580_bb0045","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/cid\/ciae537","article-title":"Long-term dynamics of measles virus\u2013specific neutralizing antibodies in children vaccinated before 12 months of age","volume":"80","author":"van der Staak","year":"2024","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128580_bb0050","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1017\/S0950268800059203","article-title":"A study of maternally derived measles antibody in infants born to naturally infected and vaccinated women","volume":"117","author":"Brugha","year":"1996","journal-title":"Epidemiology & Infection"},{"key":"10.1016\/j.vaccine.2026.128580_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.107882","article-title":"Sero-epidemiology of measles immunoglobulin g antibodies among newborns from South-east asia and sub-Saharan africa: an observational, multicenter study","volume":"154","author":"Bokop","year":"2025","journal-title":"Int J Infect Dis"},{"issue":"94","key":"10.1016\/j.vaccine.2026.128580_bb0060","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcv.2017.07.009","article-title":"Maternal HIV infection associated with reduced transplacental transfer of measles antibodies and increased susceptibility to disease","volume":"1","author":"Jallow","year":"2017","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2026.128580_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127187","article-title":"What is the current evidence base for measles vaccination earlier than 9 months of age? Report from an informal technical consultation of the world health organization","volume":"57","author":"Varma","year":"2025","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128580_bb0075","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S1473-3099(19)30396-2","article-title":"Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis","volume":"19","author":"Nic Lochlainn","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128580_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30289-9","article-title":"Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in south African children: an open-label, randomised, non-inferiority trial","author":"Madhi","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128580_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003209","article-title":"High measles and rubella vaccine coverage and seroprevalence among zambian children participating in a measles and rubella supplementary immunization activity","volume":"5","author":"Prosperi","year":"2025","journal-title":"PLOS Global Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128580_bb0090","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/cid\/ciy964","article-title":"Measles immunity at 4.5 years of age following vaccination at 9 and 15\u201318 months of age among human immunodeficiency virus (HIV)\u2013infected, HIV-exposed\u2013uninfected, and HIV-unexposed children","volume":"69","author":"Mutsaerts","year":"2019","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"21","key":"10.1016\/j.vaccine.2026.128580_bb0095","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med"},{"issue":"10111","key":"10.1016\/j.vaccine.2026.128580_bb0100","doi-asserted-by":"crossref","first-page":"10111","DOI":"10.1016\/S0140-6736(17)31463-0","article-title":"Measles","volume":"390","author":"Moss","year":"2017","journal-title":"The Lancet"},{"issue":"suppl_1","key":"10.1016\/j.vaccine.2026.128580_bb0105","doi-asserted-by":"crossref","first-page":"S533","DOI":"10.1093\/infdis\/jir097","article-title":"Genetic characterization of measles vaccine strains","volume":"204","author":"Bankamp","year":"2011","journal-title":"J Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2026.128580_bb0110","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/S0264-410X(02)00156-1","article-title":"Clinical and serological studies on CAM-70 live attenuated measles vaccine: an 18-year survey at a pediatric clinic in Japan","volume":"20","author":"Ozaki","year":"2002","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128580_bb0115","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/00006454-199210000-00003","article-title":"Comparison of high titer Edmonston-Zagreb, Biken-CAM and schwarz measles vaccines in peruvian infants","volume":"11","author":"Berry","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2026.128580_bb0120","first-page":"205","article-title":"Measles vaccines: WHO position paper-April 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"0","key":"10.1016\/j.vaccine.2026.128580_bb0125","article-title":"Measles 2025","volume":"0","author":"Do","year":"2025","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.vaccine.2026.128580_bb0130","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1016\/j.vaccine.2021.04.012","article-title":"Effect of early measles vaccination on long-term protection: a systematic review","volume":"39","author":"Xu","year":"2021","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128580_bb0135","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/infdis\/jiab318","article-title":"Measles vaccination elicits a polyfunctional antibody response, which decays more rapidly in early vaccinated children","volume":"225","author":"Brinkman","year":"2021","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128580_bb0140","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S1473-3099(19)30395-0","article-title":"Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis","volume":"19","author":"Nic Lochlainn","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128580_bb0145","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/323346","article-title":"Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months","volume":"184","author":"Gans","year":"2001","journal-title":"J Infect Dis"},{"issue":"Supplement_1","key":"10.1016\/j.vaccine.2026.128580_bb0155","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1086\/377712","article-title":"The clinical significance of measles: a review","volume":"189","author":"Perry","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128580_bb0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0049475518804695","article-title":"Clinical profile of measles in children with special reference to infants","volume":"49","author":"Sindhu","year":"2019","journal-title":"Trop Doct"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:08:45Z","timestamp":1777576125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26003889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":30,"alternative-id":["S0264410X26003889"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128580","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Waning of measles immunity by 5\u00a0years of age following an accelerated two-dose measles vaccine schedule at 6 and 12\u00a0months in South African children: an observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128580"}}